'Ovarian cancer' diaporamas de présentation

Role of the Naturopathic P hysician in Gynecological O ncology-Making a difference

Role of the Naturopathic P hysician in Gynecological O ncology-Making a difference. Naini Kohli, ND, FABNO Consultant, Naturopathic Oncology. Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia, PA. Learning Objectives. Overview

974 views • 81 slides

805 views • 62 slides

MALIGNANT DISORDERS OF THE OVARIES

MALIGNANT DISORDERS OF THE OVARIES. Assoc. Prof. Gazi YILDIRIM, M.D. Yeditepe University, Medical Faculty Dept of Ob&Gyn. Objectives. To define Ovarian cancer To learn Risk factors for ovarian cancer Prognostic factor for ovarian cancer Diagnosis of ovarian cancer To manage

1.88k views • 60 slides

Reproductive Health

Reproductive Health. Nursing DX for Reproductive Health. Nsg Dx Discomfort/Pain Alternation in self esteem Knowledge deficit r/t self care, fertility, infertility High risk for transmission or infection r/t STD. Menstrual Cycle. Compare phases of cycle Ovarian Hormonal Endometrial

746 views • 44 slides

Suspected Gynaecological Cancer Recognition & Referral

Suspected Gynaecological Cancer Recognition & Referral. Karin Williamson Consultant Gynaecological Oncologist Nottingham University Hospitals. NICE NG12 June 2015. Replaced 2005 Guidelines Evidence based recommendations on the recognition and referral of suspected cancer.

827 views • 40 slides

Rochelle Shoretz Founder and Executive Director

Culturally Appropriate Health Communications For Women At Increased Risk. Rochelle Shoretz Founder and Executive Director. About Sharsheret.

524 views • 33 slides

Investigating the Role of Anti-Angiogenic Agents in Ovarian Cancer

Investigating the Role of Anti-Angiogenic Agents in Ovarian Cancer. Carol Aghajanian, M.D. Chief, Gynecologic Medical Oncology Memorial Sloan-Kettering Cancer Center. Phase III: GOG 218. Carboplatin/Paclitaxel - cycles 1-6 Concurrent Placebo - cycles 2-6 Placebo - cycles 7-22.

707 views • 27 slides

Background

Methodology of Conducting the Patterns of Ovarian Cancer Care and Survival in the Midwestern Region of the United States.

644 views • 24 slides

10 Minutes Talk

10 Minutes Talk. ? ? ? Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008. Ovarian cancer, MicroRNA, Exosome. Introduction Ovarian cancer. Worldwide, 6th most common in female & 125,000 deaths annually 75% diagnosed as extra-ovarian dz (EM ca 73%, Breast ca 55% & Cx ca 50% in stage 1)

815 views • 20 slides

So, What Can You Do with a BBH Degree?

513 views • 19 slides

Breast Cancer, Genes, and the Environment

Breast Cancer, Genes, and the Environment UNC-Chapel Hill Center for Environmental Health and Susceptibility Funded by the National Institute of Environmental Health Sciences (NIEHS), P30ES10126 10/2006 Goals To learn about breast cancer risks

723 views • 18 slides

Improving Cancer Outcomes in Camden

Improving Cancer Outcomes in Camden. Dr Lucia Grun 19 March 2014. International Cancer Benchmarking Partnership: 5 year relative survival, patients diagnosed 1995-2007: Coleman et al, Lancet 2011.

312 views • 14 slides

ovarian cancer treatment in india at mumbai at low price

Ovarian Cancer, Ovarian Treatment India, Ovarian Cancer Symptoms India, Stages India, Diagnosis India, Risk Factors India, Symptoms India, Warning Signs India, Ovarian Cancer Symptoms India, Ovarian Cancer Treatment India, Stages India, Cancerous Growth India, Prognosis India, India Hospital Tour India, Cancer Of The Ovaries India, Carcinoma India, Ovaries India, Ovarian, Prevention, Genetics, Ovarian Neoplasms, Ovary, Egg Cells, Ovarian Cancer Alliance, Women, Endocrine System Diseases, Reproduction, ovarian cancer information

864 views • 12 slides

cancers

my tech yes project

108 views • 10 slides

cancers

my TechYes project

251 views • 10 slides

cancers

my techyes project

104 views • 10 slides

peritoneal cancer

peritoneal cancer

294 views • 8 slides

Peritoneal Cancer

Peritoneal Cancer

237 views • 8 slides

Primary Peritoneal Cancer

Primary Peritoneal Cancer

367 views • 8 slides

Roukos DH and Briasoulis E (2007) Individualized preventive and therapeutic management of hereditary breast

? ?????????? ??? ????????????? ?????????. Figure 1 Proposed individualized management algorithm for women at high risk for the hereditary breast ovarian cancer (HBOC) syndrome. Roukos DH and Briasoulis E (2007) Individualized preventive and therapeutic management of hereditary breast

199 views • 1 slides